ArticleFrontiers in pharmacology2021

Gaboxadol in Fragile X Syndrome: A 12-Week Randomized, Double-Blind, Parallel-Group, Phase 2a Study.

Dejan B Budimirovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.